MedTrace Logo

An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa

NCT04868916 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2025-04-25

No results posted yet for this study

Summary

The purpose of the study is to identify a cohort of Japanese participants with X-linked retinitis pigmentosa (XLRP) associated with pathogenic variants in the retinitis pigmentosa GTPase regulator (RPGR) gene and to investigate their associated phenotype.

Conditions

  • X-Linked Retinitis Pigmentosa

Sponsors & Collaborators

  • Janssen Pharmaceutical K.K.

    lead INDUSTRY

Principal Investigators

  • Janssen Pharmaceutical K.K., Japan Clinical Trial · Janssen Pharmaceutical K.K.

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-26
Primary Completion
2024-04-23
Completion
2024-04-23

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04868916 on ClinicalTrials.gov